MedTrace Logo

Blueberry Intake and Infant Gut Health

NCT05006989 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2025-04-30

No results posted yet for this study

Summary

The objective of this project is to investigate the effects of blueberries on gut microbiota, inflammation and innate immunity in breastfed infants during early complementary feeding (\~5 to 12 months of age).

Conditions

  • Infant Development

Interventions

OTHER

Blueberry Powder

Administered one packet per day (10 grams/packet) and participants consume up to 10 grams per day.

OTHER

Placebo Powder

Administered one packet per day (10 grams/packet) and participants consume up to 10 grams per day.

Sponsors & Collaborators

  • U.S. Highbush Blueberry Council

    collaborator OTHER

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Minghua Tang, PhD · University of Colorado Denver | Anschutz

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
4 Months
Max Age
5 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2024-10-30
Completion
2025-03-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05006989 on ClinicalTrials.gov